Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the field of hematological malignancies. Novel approaches such as targeted drugs, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering promise for more successful treatment opti